PT2391382E - Preparado farmacêutico contendo lipase de origem bacteriana - Google Patents

Preparado farmacêutico contendo lipase de origem bacteriana Download PDF

Info

Publication number
PT2391382E
PT2391382E PT97763460T PT09776346T PT2391382E PT 2391382 E PT2391382 E PT 2391382E PT 97763460 T PT97763460 T PT 97763460T PT 09776346 T PT09776346 T PT 09776346T PT 2391382 E PT2391382 E PT 2391382E
Authority
PT
Portugal
Prior art keywords
lipase
pharmaceutical preparation
bacterial origin
bacterial
origin
Prior art date
Application number
PT97763460T
Other languages
English (en)
Inventor
Manfred Kurfürst
Rainer Friedel
Olaf Friedrich
Christian Rämsch
Silke Hüttler
Original Assignee
Nordmark Arzneimittel Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordmark Arzneimittel Gmbh & Co Kg filed Critical Nordmark Arzneimittel Gmbh & Co Kg
Publication of PT2391382E publication Critical patent/PT2391382E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97763460T 2009-01-29 2009-01-29 Preparado farmacêutico contendo lipase de origem bacteriana PT2391382E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/000566 WO2010085975A1 (de) 2009-01-29 2009-01-29 Pharmazeutisches präparat enthaltend lipase bakteriellen ursprungs

Publications (1)

Publication Number Publication Date
PT2391382E true PT2391382E (pt) 2014-08-22

Family

ID=41091375

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97763460T PT2391382E (pt) 2009-01-29 2009-01-29 Preparado farmacêutico contendo lipase de origem bacteriana

Country Status (13)

Country Link
US (2) US20110293590A1 (pt)
EP (2) EP2786761A1 (pt)
JP (1) JP5970189B2 (pt)
CN (1) CN102231988A (pt)
BR (1) BRPI0922653B8 (pt)
CY (1) CY1115519T1 (pt)
DK (1) DK2391382T3 (pt)
ES (1) ES2488407T3 (pt)
HR (1) HRP20140715T1 (pt)
PL (1) PL2391382T3 (pt)
PT (1) PT2391382E (pt)
SI (1) SI2391382T1 (pt)
WO (1) WO2010085975A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2165717A1 (de) 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
EP2295039B2 (de) 2009-08-28 2022-10-26 Nordmark Pharma GmbH Verfahren zur Herstellung von Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und hiernach hergestellte Pankreatin-Pellets
EP2489349B1 (de) 2011-02-17 2014-05-28 Nordmark Arzneimittel GmbH & Co.KG Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und Verfahren zu deren Herstellung
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
WO2013146529A1 (ja) * 2012-03-28 2013-10-03 不二製油株式会社 ランダムエステル交換油脂の製造方法
DE102015114857A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
DE102017104480A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Wässrige Lösung von Burlulipase umfassend Kalziumionen
DE102017104501A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung umfassend einen Träger und einen Überzug enthaltend wenigstens eine Lipase
DE102017104482A1 (de) * 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung umfassend Pankreatin und einen lipasehaltigen Überzug
KR20220106738A (ko) 2019-08-30 2022-07-29 코덱시스, 인코포레이티드 조작된 리파제 변이체

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2189948A (en) 1938-10-31 1940-02-13 Griffith Laboratories Sterilization of pancreatin
DE2923279C2 (de) 1979-06-08 1987-07-09 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von Pankreatin-Pellets und diese enthaltende Arzneimittel
US5063160A (en) * 1989-03-16 1991-11-05 Olin Corporation Identification, characterization, and method of production of a novel microbial lipase
JP3025528B2 (ja) 1989-11-24 2000-03-27 ビオヘミー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング パンクレアチン製剤
DK173590D0 (da) * 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
CA2110497C (en) 1991-07-01 2005-04-19 Reinhard Braatz Use of bacterial lipases for producing drugs for maldigestion therapy
DE4227385A1 (de) 1992-08-19 1994-02-24 Kali Chemie Pharma Gmbh Pankreatinmikropellets
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
DE19724845A1 (de) * 1996-08-28 1998-03-05 Solvay Pharm Gmbh Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen
US6270723B1 (en) 1998-06-15 2001-08-07 Bbi Bioseq, Inc. Rapid cryobaric sterilization and vaccine preparation
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
ES2227169T3 (es) * 2000-04-06 2005-04-01 The Hannah Research Institute Emulsiones estabilizadas por proteina.
AT502588B1 (de) * 2002-11-26 2010-05-15 Brenner Franz Papaya-mus
EP1486415A1 (en) 2003-06-12 2004-12-15 SSP Technology A/S Wind turbine blade and method of manufacturing a blade root
US6908789B1 (en) 2003-12-15 2005-06-21 Intel Corporation Method of making a microelectronic assembly
DE602005009677D1 (de) * 2004-03-22 2008-10-23 Solvay Pharm Gmbh Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin, mit tensiden
SI2198880T1 (sl) * 2004-10-14 2017-02-28 Eli Lilly And Co. Sestavki, ki vsebujejo lipazo, proteazo in amilazo, za zdravljenje pankreasne insuficience
DE102004056340B4 (de) 2004-11-22 2010-11-18 Repower Systems Ag Vorrichtung und Verfahren zur Montage und/oder Demontage eines Bauteils einer Windkraftanlage
DE102005014868A1 (de) 2005-03-30 2006-10-05 Repower Systems Ag Offshore-Windenergieanlage mit rutschfesten Füßen
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
DE102006021982C5 (de) 2006-05-10 2010-10-07 Repower Systems Ag Gestaffelt abschaltbarer Windpark
SG186648A1 (en) * 2007-02-20 2013-01-30 Aptalis Pharma Ltd Stable digestive enzyme compositions
DE102007014863A1 (de) 2007-03-26 2008-10-02 Repower Systems Ag Verfahren zum Betreiben einer Windenergieanlage
AU2008239737A1 (en) * 2007-04-13 2008-10-23 Beth Israel Deaconess Medical Center, Inc. Novel nutritional food products for improved digestion and intestinal absorption
DE102008012664A1 (de) 2008-01-30 2009-08-06 Repower Systems Ag Windenergieanlage und ein Turm oder Turmsegment und eine Türzarge dafür
EP2165717A1 (de) 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
EP2295039B2 (de) 2009-08-28 2022-10-26 Nordmark Pharma GmbH Verfahren zur Herstellung von Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und hiernach hergestellte Pankreatin-Pellets
EP2489349B1 (de) 2011-02-17 2014-05-28 Nordmark Arzneimittel GmbH & Co.KG Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
CN102231988A (zh) 2011-11-02
SI2391382T1 (sl) 2014-10-30
EP2391382B1 (de) 2014-06-04
DK2391382T3 (da) 2014-08-25
BRPI0922653A2 (pt) 2016-01-05
ES2488407T3 (es) 2014-08-27
US20160287679A1 (en) 2016-10-06
BRPI0922653B1 (pt) 2021-04-13
BRPI0922653B8 (pt) 2021-05-25
WO2010085975A1 (de) 2010-08-05
EP2391382A1 (de) 2011-12-07
US10596235B2 (en) 2020-03-24
US20110293590A1 (en) 2011-12-01
HRP20140715T1 (hr) 2014-09-26
JP2012516289A (ja) 2012-07-19
JP5970189B2 (ja) 2016-08-17
EP2786761A1 (de) 2014-10-08
CY1115519T1 (el) 2017-01-04
PL2391382T3 (pl) 2014-11-28

Similar Documents

Publication Publication Date Title
HK1250313A1 (zh) 穩定的藥物組合物和使用所述組合物的方法
PL2391382T3 (pl) Preparat farmaceutyczny zawierający lipazę pochodzenia bakteryjnego
IL240098A (en) Disinfectant containing digestive enzymes
ZA201105434B (en) Fermentation broth formulations
EP2429948A4 (en) Aerogel compositions and methods of making and using them
IL215612A (en) Digestive enzyme preparations are coated
EP2504020A4 (en) DAPTOMYCIN FORMULATIONS
EP2534174A4 (en) Preparation and / or purification of oligonucleotide conjugates
IL215865B (en) Meloxicam formulation
LT2504445T (lt) Angliavandenių fermentacija
IL217072A0 (en) Method of drug delivery
EP2635287A4 (en) NEDD8 ACTIVATOR ENZYME INHIBITOR ADMINISTRATION
EP2513869A4 (en) Level of detail processing
IL219018A (en) Radzolid Pharmaceuticals and Uses
GB0910078D0 (en) Uses of mannose-6-phosphate
EP2508598A4 (en) PREPARATION OF LIPASE POWDER AND USE THEREOF
EP2404891A4 (en) PROCESS FOR THE PREPARATION OF ACYLBENZENES
GB0922537D0 (en) Pharmaceutical preparation
EP2459540A4 (en) PREPARATION OF FIPAMEZOLE
PL2263445T3 (pl) Grupa doniczek
EP2415465A4 (en) STABILIZATION-FREE PHARMACEUTICAL TETRAHYDROLIPSTATINE COMPOSITIONS
GB0906971D0 (en) Pharmaceutical preparation
GB201115179D0 (en) Pharmaceutical preparation
GB201115173D0 (en) Pharmaceutical preparation
GB0911749D0 (en) Preparation of glycoside esters